The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

MRNA FINANCIAL STATEMENTS

Moderna Inc — balance sheet, income statement and cash flow trends

MRNAModerna Inc

🇺🇸 USA · US · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
010 B20 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue2.2 B $Gross Profit-280 M $ · -13%Operating Income-3.3 B $ · -149%Pre-tax Income-3.1 B $ · -139%Net Income to Owners-3.2 B $ · -141%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue2.2 B $-27.2%
Gross Profit-280 M $-117.5%
Operating Income-3.3 B $—
EBITDA-2.9 B $—
Net Income to Owners-3.2 B $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
010 B20 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets11 B
  • Equity6.8 B $62%
  • Current Liabilities2.5 B $23%
  • Long-term Liabilities1.7 B $15%

Key Figures

YoY change
Total Assets11 B $-8.7%
Total Liabilities4.2 B $+60.9%
Total Equity6.8 B $-28.1%
Cash & ST Investments1.7 B $-66.4%
Total Debt1.2 B $+66.7%
Net Debt-488 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
05 B10 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-1 B-500 M0500 M-1.1 B $Operating905 M $Investing590 M $Financing443 M $Net Change

Key Figures

YoY change
Operating Cash Flow-1.1 B $—
Capital Expenditures171 M $-78.7%
Free Cash Flow-1.2 B $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on MRNA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 4, 26. This content is for informational purposes only and is not investment advice.